Kelly A. Kramer
About Kelly A. Kramer
Kelly A. Kramer, 57, is an independent director at Coinbase (COIN) serving since December 2020. She is Audit and Compliance Committee Chair and a member of the Compensation Committee, and is designated an “audit committee financial expert.” Kramer holds a B.S. in Mathematics from Purdue University and brings deep CFO and finance leadership experience from Cisco and GE Healthcare, aligning strongly with board oversight of financial reporting and risk.
Past Roles
| Organization | Role | Tenure | Committees/Impact |
|---|---|---|---|
| Cisco Systems, Inc. | Executive Vice President & Chief Financial Officer | Jan 2015 – Dec 2020 | Led corporate finance and reporting; CFO oversight across a global technology firm |
| Cisco Systems, Inc. | SVP, Corporate Finance; SVP, Business Technology & Operations Finance | Jan 2012 – Jan 2015 | Senior finance leadership roles supporting operations and technology finance |
| GE Healthcare Systems | Vice President & CFO | Not disclosed | Senior finance leadership in healthcare systems |
| GE Healthcare Diagnostic Imaging & Biosciences (GE) | Various finance roles | Not disclosed | Finance leadership across divisions |
External Roles
| Organization | Role | Tenure | Notes |
|---|---|---|---|
| Gilead Sciences, Inc. | Director | Since Aug 2016 | Public company directorship |
| Snowflake Inc. | Director | Since Jan 2020 | Public company directorship |
| Privately held company | Director | Current | Company not named |
Board Governance
- Independence: Board determined Kramer is independent under Nasdaq and SEC rules. All board committees are entirely independent.
- Committee assignments: Audit and Compliance Committee (Chair); Compensation Committee (Member).
- Audit Committee scope: Oversees external audit selection, independence, internal controls, enterprise risk (including cybersecurity), disclosure controls, legal/compliance risk, and related party transaction oversight.
- Compensation Committee scope: Approves/oversees executive and director compensation, equity plans, clawback policy, pay equity and D&I oversight.
- Attendance and engagement: In 2024 the Board met 5 times; Audit 8; Compensation 4; Nominating 5. Each director attended ≥75% of applicable meetings except Andreessen and Ehrsam (>60%); Kramer met the ≥75% threshold. Independent directors meet in regular executive sessions.
- Lead Independent Director: Fred Wilson, with robust responsibilities for agendas, executive sessions, liaison and independent leadership.
Fixed Compensation
| Component | 2024 Amount | Terms |
|---|---|---|
| Annual RSU Award | $325,000 | Increased from $300,000 effective April 18, 2024; vests on earlier of 1 year from grant or next annual meeting |
| Additional RSU – Audit Chair | $35,000 | RSUs for chair service; pro-rated if mid-cycle; same vest convention as Annual Award |
| Additional RSU – Compensation Member | $15,000 | RSUs for committee membership; pro-rated if mid-cycle; same vest convention |
| Special Litigation Committee Fees (cash) | $67,026 | Cash fees for special litigation committee service (Kramer and Rajaram only) |
| Stock Awards (grant-date fair value) | $374,819 | RSUs granted/valued per ASC 718 |
| Total 2024 Director Compensation | $441,844 | Sum of cash and stock award value |
RSU vesting/acceleration details:
- 2024 RSU grant: 1,533 shares granted June 14, 2024; full vest June 14, 2025, subject to continued service.
- Director RSU awards accelerate in full upon consummation of a Corporate Transaction under the 2021 Plan.
Program characteristics:
- Director compensation delivered exclusively in equity RSUs (annual and role-based) with limited cash only for special litigation committee service; non-employee director compensation capped at $1,000,000 combined cash + equity per calendar year.
Performance Compensation
| Performance Metrics Tied to Director Compensation | Status |
|---|---|
| None – Director compensation is time-based RSUs (no performance-conditioned director awards disclosed) | Not applicable |
Other Directorships & Interlocks
- Current public boards: Gilead Sciences; Snowflake.
- Interlocks/conflicts: No related-party transactions disclosed involving Kramer; Audit Committee reviews related-party transactions. Aon vendor relationship relates to director Christa Davies, not Kramer.
Expertise & Qualifications
- Designated “audit committee financial expert.”
- Former Fortune 100 CFO and senior finance leader (Cisco; GE Healthcare), with extensive financial reporting, controls, risk oversight, and capital allocation experience.
Equity Ownership
| Item | Detail |
|---|---|
| Total beneficial ownership | 32,118 shares of Class A common stock (beneficial ownership <1% of outstanding) |
| Unvested director RSUs (as of 12/31/2024) | 1,533 shares (granted 6/14/2024; vest 6/14/2025) |
| Ownership guidelines | Non-employee directors must hold ≥$350,000 in COIN shares within 5 years (raised from $250,000 in Apr 2024); as of 12/31/2024 all non-employee directors met or were on track. |
| Hedging/pledging | Hedging prohibited; pledging prohibited unless approved by Chief Legal Officer. |
Governance Assessment
-
Strengths
- Independent director; Audit Chair; Compensation Committee member; designated financial expert—strong alignment with investor expectations for oversight of financial reporting, risk, and pay governance.
- Robust committee mandates (enterprise risk, cybersecurity, disclosure controls, clawback policy) and fully independent committee composition.
- Director ownership guidelines tightened to $350k; broad compliance/on-track status improves alignment.
- Attendance at or above the 75% threshold across board/committees in 2024 demonstrates engagement.
-
Watchpoints
- Controlled company status due to CEO voting control can structurally reduce certain governance requirements, though Coinbase opts into majority independence and independent committees. Continued vigilance by Audit Chair is important.
- Multiple outside public boards (Gilead, Snowflake) imply meaningful time commitments; no conflicts disclosed, but investors should monitor for potential future interlocks or vendor ties.
-
Compensation & shareholder signals
- Director comp heavily equity-based RSUs with role-based RSUs (audit chair/member supplements); limited cash only for special litigation committee service—generally favorable alignment.
- Executive say-on-pay support was >99% in 2022, indicating broad shareholder alignment with compensation governance at that time.
-
Related-party and red flags
- No related-party transactions disclosed for Kramer; Section 16(a) compliance noted, with late filings only for other executives in 2024; none referenced for Kramer.